713-928-2355
Menu
  • Home
  • Practice Areas
    • Personal Injury and Dangerous Devices
      • Philips® CPAP Recall
      • Knee Implant Failure
      • Elbow Implant Failure
      • Shoulder Replacement Lawsuit
      • 3M Earplug Lawsuit
    • Drug Injury
      • Purdue Opioid Claim
      • Invokana © and other SGLT2 Drugs Risk of Fournier Gangrene
      • Invokana® Increased Risk of Leg and Foot Amputations
      • Shingles Vaccine Lawsuit Zostavax®
    • Birth Injury
      • Depakote®
      • Dilantin®
      • Paxil®
      • Zofran®
      • Zoloft®
  • Maritime Injury
  • Buffalo Bayou or SJ River Claim
  • About
    • Victor Longo
  • Testimonials
  • Blog
  • Contact Us
Home / Uncategorized

Uncategorized

  • Blog

Philips Respironics Initiates Recall of Trilogy Ventilator

Respironics, Inc. has announced a worldwide recall of approximately 600 Philips Respironics Trilogy Ventilators. The voluntary recall is meant to address a potentially defective component on the Trilogy Ventilator power management board, which...
  • More
  • 0
  • 0
  • 0
Posted March 1, 2014 | by victorlongo |in Uncategorized

FDA to Review Possible Risk of Heart Failure Associated with Diabetes Drug

The U.S. Food and Drug Administration (FDA) recently released a safety announcement stating that they have requested clinical trial data from the manufacturer of saxagliptin to investigate a possible association between the use of the type 2...
  • More
  • 0
  • 0
  • 0
Posted February 12, 2014 | by victorlongo |in Uncategorized

Baxter Recalls Dialysis Solution after Discovering Mold Contamination

The U.S. Food and Drug Administration (FDA) has published details of a product recall affecting some dialysis patients.  The FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to...
  • More
  • 0
  • 0
  • 0
Posted February 1, 2014 | by victorlongo |in Uncategorized

FDA Evaluating Risk of Stroke, Heart Attack and Death with FDA-approved Testosterone Products

A possible risk of stroke, heart attack, and death in men has been linked to FDA-approved testosterone products, according to an FDA Safety Announcement.  The agency, responsible for protecting the public health, has been monitoring this risk and...
  • More
  • 0
  • 0
  • 0
Posted January 31, 2014 | by victorlongo |in Uncategorized

Merck Recalls Liptruzet

The combination cholesterol drug Liptruzet, which was introduced in May, is being recalled by Merck.  The recall is due to a packaging defect that could reduce effectiveness of the drug. On its website, Merck said the recall will clear out the...
  • More
  • 0
  • 0
  • 0
Posted January 20, 2014 | by victorlongo |in Uncategorized

Popular Fibroid Removal Procedure May Spread Cancer

  According to a recent report, a procedure used to remove fibroids may actually cause the cancer to spread.  Morcellation, a minimally invasive procedure is a popular method for removing uterine fibroids.  Some experts now believe that the...
  • More
  • 0
  • 0
  • 0
Posted December 27, 2013 | by victorlongo |in Uncategorized

FDA Warns of Serious Skin Reactions with Anti-Seizure Drug Onfi

In a recent Safety Announcement, the U.S. Food and Drug Administraion (FDA) warned the public that the anti-seizure drug Onfi (clobazam) may cause rare sskin reaction that can result in permanent harm and in some cases, death. Changes to the Onfi...
  • More
  • 0
  • 0
  • 0
Posted December 12, 2013 | by victorlongo |in Uncategorized

FDA Requires Removal of Restrictions on Type 2 Diabetes Medication

In a recent U.S. Food and Drug Administration (FDA) Safety Update, the agency announced that recent data for rosiglitazone-containing drugs, including Avandia, Avandamet, Avandaryl, and generics, do not show an increased risk of heart attack...
  • More
  • 0
  • 0
  • 0
Posted November 26, 2013 | by victorlongo |in Uncategorized

FDA Links Potiga to Retinal Abnormalities and Blue Skin Discoloration

The U.S. Food and Drug Administration (FDA) issued a Safety Communication warning the public that the anti-seizure medication Potiga (ezogabine) can cause blue skin discoloration and eye abnormalities characterized by pigment changes in the...
  • More
  • 0
  • 0
  • 0
Posted November 8, 2013 | by victorlongo |in Uncategorized

Bleeding in Spinal Column from Lovenox Use: FDA Update

The U.S. Food and Drug Administration (FDA) released a Safety Announcement including updated recommendations to decrease risk of spinal column bleeding and paralysis in patients on low molecular weight haprins. The agency is recommending...
  • More
  • 0
  • 0
  • 0
Posted November 6, 2013 | by victorlongo |in Uncategorized

Class 1 Recall on Bard LifeStent Solo Vascular Stent

The FDA has issued safety information regarding a Class 1 recall of Bard LifeStent Solo Vascular Stent.  The product has been recalled due to deployment issues that range from failure to deploy, partial deployment, and difficult deployment.  The...
  • More
  • 0
  • 0
  • 0
Posted October 18, 2013 | by victorlongo |in Uncategorized

Antidepressants and Diabetes Linked in University Study

Researchers at the University of Southampton have warned that some antidepressants may pose a risk of type 2 diabetes.  A systematic review carried out by the University showed a higher risk of type 2 diabetes in people taking antibiotics...
  • More
  • 0
  • 0
  • 0
Posted September 30, 2013 | by victorlongo |in Uncategorized
  • « First
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • …
  • Next »
  • Last »

LikeBox

Phone: 713-928-2355
Fax: 1-713-923-1043
5728 Hood Street
Houston, TX 77023
Disclaimer/Warning This site is a public resource for general information. Nothing in this website should be considered legal advice. Communications by you through this website do not establish an attorney-client relationship. Our professional obligations require that before accepting any new client, we must determine whether any conflicts exist with current or former clients. To inquire about legal representation, please call or email us. An attorney-client relationship will not be created by placing a call or sending an email. Any medical decision is important. You should not stop taking any prescribed medication unless advised to do so by your doctor. Consult your doctor before making any medical decision and do not rely upon this website in making any medical decision. Attorney licensed in Texas. Attorney not certified by the Boards of Legal Specialization in any state. Not all states have board certifications. Attorney Victor Longo is responsible for the content of this advertisement. Representation is not available in all states and Longo Legal, PLLC is not accepting cases in all states. Longo Legal, PLLC may associate with other law firms in other states and jurisdictions as required. Cases will likely be referred to other lawyers for handling. © Copyright 2016 Longo Legal